Clinical Trials

166 enrolled 11 charts

Carcinoma, Non-Small-Cell Lung

NCT01248247 2022-01-12

BATTLE-2 Program: A Biomarker-Integrated Targeted Therapy Study in Previously Treated Patients With Advanced Non-Small Cell Lung Cancer

334 enrolled 14 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00647426 2019-10-22

Phase II Study of Sorafenib + Carboplatin and Docetaxel in First Line Treatment of Stage IIIB/IV NSCLC

7 enrolled 5 charts

Carcinoma, Non-Small-Cell Lung

NCT00754923 2019-03-06

Sorafenib in Treating Non-Smokers or Former Light Smokers With Relapsed or Refractory Stage IIIB or Stage IV Non-Small Cell Lung Cancer

11 enrolled 8 charts

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00801801 2017-05-17

Study of Low Dose Chemotherapy Plus Sorafenib as Initial Therapy for Patients With Advanced Non-Squamous Cell NSCLC

5 enrolled 7 charts

Carcinoma, Non-Small-Cell Lung

NCT00454194 2017-03-21

Pemetrexed Disodium With or Without Sorafenib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

110 enrolled 15 charts

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00098540 2016-12-29

Sorafenib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

46 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00609804 2016-04-08

Sorafenib and Erlotinib or Sorafenib Alone in Advanced Non-Small Cell Lung Cancer Progressing on Erlotinib

53 enrolled 7 charts

Carcinoma, Non-Small-Cell Lung

NCT00411671 2016-02-11

BATTLE Program: Sorafenib in Patients With NSCLC

105 enrolled 8 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT01159327 2015-11-11

Study of Sorafenib Maintenance in Patients With ED-SCLC After Response to Induction Chemotherapy

13 enrolled

Small Cell Lung Carcinoma

NCT00726986 2014-11-19

Sorafenib, Cisplatin, and Etoposide in Treating Patients With Extensive-Stage Small Cell Lung Cancer

18 enrolled 9 charts

Lung Neoplasms

NCT00101413 2013-10-30

BAY43-9006 - Phase II Study in Non-Small Cell Lung Carcinoma (NSCLC)

52 enrolled 11 charts

Carcinoma, Non-Small-Cell Lung, Neoplasms

NCT00922584 2013-08-21

Sorafenib Treatment in Non-Small Cell Lung Cancer After Failure of Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitor

65 enrolled

Carcinoma, Non-Small-Cell Lung

NCT00107432 2013-06-05

Sorafenib Tosylate in Treating Patients With Malignant Mesothelioma.

Other solid neoplasmThoracic

44 enrolled

Mesothelioma, Malignant, Solitary Fibrous Tumor, Pleural

NCT00098254 2012-05-02

BAY 43-9006 (Sorafenib) to Treat Relapsed Non-Small Cell Lung Cancer

37 enrolled 17 charts

Carcinoma, Non-Small-Cell Lung, Neoplasms

NCT00456716 2010-03-04

Sorafenib in BAC or Never-Smokers With Lung Adenocarcinoma

5 enrolled

Adenocarcinoma of Lung, Lung Neoplasms

NCT00801385 2009-08-25

Sorafenib and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Has Not Responded to Chemotherapy

Phase 2 Unknown

47 enrolled

Other solid neoplasmThoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00794859 2009-08-04

SMS

Phase 2 Unknown

54 enrolled

Mesothelioma

NCT00722969 2009-03-03

Erlotinib and Sorafenib in Chemonaive Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer

Phase 2 Unknown

48 enrolled